Healthcare-payments software company Waystar seeks about $1 billion in IPO
By Steve Gelsi
Waystar serves about 30,000 clients that represent more than one million providers.
Waystar Holding Corp., a healthcare-payments software company, said Tuesday it plans to raise about $1 billion in its initial public offering.
The Lehi, Utah-based company plans to trade under the symbol WAY on the Nasdaq.
Waystar plans to offer 45 million shares at an estimated price range of $20 to $23 a share in its upcoming initial public offering.
At the midpoint of the range, Waystar's IPO will raise about $967.5 million with underwriters JPMorgan Chase & Co. (JPM), Goldman Sachs Group Inc. (GS) and Barclays PLC (BCS).
With 173.4 million shares outstanding, including shares allotted to underwriters, Waystar's market capitalization will be about $3.7 billion. That's at the midpoint of the estimated price range or $21.50 a share.
Founded in 2000, Waystar is backed by EQT AB (SE:EQT), Canada Pension Plan Investment Board, Bain Capital and Francisco Partners.
The company reported a full-year 2023 net loss of $51.33 million and revenue of $791 million, compared to a 2022 net loss of $51.5 million and revenue of $704.9 million.
Waystar, which came out of the combination of Navicure and ZirMed in 2017, makes claims-management and patient-payment software to help its network of about 30,000 clients, representing more than one million providers.
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-28-24 0801ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks